O’Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome

O’Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome

Although intravesical injection of onabotulinumtoxinA (BoNT-A) has been proved promising in treating patients with interstitial cystitis/bladder pain syndrome (IC/BPS), what kind of patients that may benefit from this treatment remains unclear. This study investigated the predictors for a successfu...

Full description

Bibliographic Details
Main Authors: Yuh-Chen Kuo, Hann-Chorng Kuo
Format: Article
Language:English
Published: MDPI AG 2015-07-01
Series:Toxins
Subjects:
interstitial cystitis
onabotulinumtoxin A
treatment
predictive factors
Online Access:http://www.mdpi.com/2072-6651/7/8/2860

Internet

http://www.mdpi.com/2072-6651/7/8/2860

Similar Items